Clinical Trial Update: SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating SS1P with pentostatin and cyclophosphamide for mesothelioma and related cancers has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Mesothelioma
• Pancreatic Neoplasms

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pentostatin (pentostatin)
• SS1P

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Mesothelioma, Adenocarcinoma of Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-06